Aptorum Group Limited (NASDAQ:APM – Get Free Report) shares were down 3.5% during mid-day trading on Thursday . The company traded as low as $1.02 and last traded at $1.11. Approximately 122,577 shares changed hands during mid-day trading, a decline of 82% from the average daily volume of 685,190 shares. The stock had previously closed at $1.15.
Aptorum Group Trading Down 1.3 %
The firm has a 50-day simple moving average of $1.26 and a 200 day simple moving average of $1.67.
About Aptorum Group
Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A.
Further Reading
- Five stocks we like better than Aptorum Group
- Want to Profit on the Downtrend? Downtrends, Explained.
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- When to Sell a Stock for Profit or Loss
- DuPont’s Electronics Spinoff: The Start of Something Big
- Trading Halts Explained
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for Aptorum Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptorum Group and related companies with MarketBeat.com's FREE daily email newsletter.
